Common use of Nasdaq Compliance Clause in Contracts

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Market"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") or the NASD is contemplating terminating such registration or listing.

Appears in 3 contracts

Samples: Stock Purchase Agreement (United Therapeutics Corp), Securities Purchase Agreement (Sipex Corp), Securities Purchase Agreement (Sipex Corp)

AutoNDA by SimpleDocs

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Market")Nasdaq, and the Company has taken no action designed tonot been contacted by the National Association of Securities Dealers, Inc. ("NASD"), either orally or likely to have the effect ofin writing, terminating the registration concerning potential delisting of the Common Stock under the Exchange Act or de-listing the Common Stock from the Nasdaq NASDAQ National Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") or the NASD is contemplating terminating such registration or listingMarket System.

Appears in 3 contracts

Samples: Document Securities Purchase Agreement (Imagex Com Inc), Securities Purchase Agreement (Imagex Com Inc), Stock Purchase Agreement (Restoration Hardware Inc)

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Stock Market"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing delisting the Common Stock from the Nasdaq National Stock Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") or the NASD is contemplating terminating such registration or listing.

Appears in 3 contracts

Samples: Stock Purchase Agreement (Pharmacopeia Inc), Stock Purchase Agreement (Aurora Biosciences Corp), Stock Purchase Agreement (Pharmacopeia Inc)

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act and and, as of the date hereof, is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Stock Market"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing delisting the Common Stock from the Nasdaq National Stock Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") or the NASD is contemplating terminating such registration or listing.

Appears in 3 contracts

Samples: Stock and Warrant Purchase Agreement (Hollis Eden Pharmaceuticals Inc /De/), Stock Purchase Agreement (Amylin Pharmaceuticals Inc), Stock Purchase Agreement (Amylin Pharmaceuticals Inc)

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Market")Nasdaq, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing delisting the Common Stock from Nasdaq. The Company has not been notified by Nasdaq of any action or potential action by Nasdaq or of any violation of any Nasdaq Rules that could result in the Nasdaq National Market, nor has delisting of the Company received any notification that the Securities and Exchange Commission (the "SEC") or the NASD is contemplating terminating such registration or listingCompany's Common Stock from Nasdaq.

Appears in 3 contracts

Samples: Common Stock and Warrant Purchase Agreement (Frazier Healthcare Ii Lp), Warrant Purchase Agreement (MPM Bio Ventures Iii Lp), Common Stock and Warrant Purchase Agreement (Alta Partners)

Nasdaq Compliance. The Company's ’s Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The the Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Stock Market"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing delisting the Common Stock from the Nasdaq National Stock Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") or the NASD is contemplating terminating such registration or listing.

Appears in 2 contracts

Samples: Stock Purchase Agreement (Tivo Inc), Stock Purchase Agreement (Tivo Inc)

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National MarketNasdaq"), and the Company has taken no action designed tonot been contacted by the National Association of Securities Dealers, Inc. ("NASD"), either orally or likely to have the effect ofin writing, terminating the registration concerning potential delisting of the Common Stock under the Exchange Act or de-listing the Common Stock from the Nasdaq NASDAQ National Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") or the NASD is contemplating terminating such registration or listingMarket System.

Appears in 2 contracts

Samples: Stock Purchase Agreement (Restoration Hardware Inc), Stock Purchase Agreement (Restoration Hardware Inc)

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Market"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") SEC or the NASD is contemplating terminating such registration or listing.

Appears in 2 contracts

Samples: Stock Purchase Agreement (Osi Pharmaceuticals Inc), Stock Purchase Agreement (Osi Pharmaceuticals Inc)

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act Act, and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Stock Market"), and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing delisting the Common Stock from the Nasdaq National Stock Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") or the NASD is contemplating terminating such registration or listing.

Appears in 2 contracts

Samples: Note Purchase Agreement (Micro Therapeutics Inc), Note Purchase Agreement (Micro Therapeutics Inc)

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The the Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Stock Market"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing delisting the Common Stock from the Nasdaq National Stock Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") or the NASD is contemplating terminating such registration or listing.

Appears in 2 contracts

Samples: Stock Purchase Agreement (Endocardial Solutions Inc), Stock Purchase Agreement (Incyte Pharmaceuticals Inc)

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National MarketNASDAQ NATIONAL MARKET"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") SEC or the NASD National Association of Securities Dealers, Inc. is contemplating terminating such registration or listing.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Aradigm Corp), Securities Purchase Agreement (Aradigm Corp)

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act of 1934, as amended (the "Exchange Act"), and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Stock Market"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing delisting the Common Stock from the Nasdaq National Stock Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") or the NASD is contemplating terminating such registration or listing.

Appears in 2 contracts

Samples: Stock Purchase Agreement (Intrabiotics Pharmaceuticals Inc /De), Common Stock and Warrant Purchase Agreement (Intrabiotics Pharmaceuticals Inc /De)

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act Act, and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Stock Market"), and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing delisting the Common Stock from the Nasdaq National Stock Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") or the NASD is contemplating terminating such registration or listing.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Micro Investment LLC), Securities Purchase Agreement (Micro Therapeutics Inc)

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act Act, and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Stock Market"), and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing delisting the Common Stock from the Nasdaq National Stock Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") or the NASD is contemplating terminating such registration or listing.

Appears in 2 contracts

Samples: Note Purchase Agreement (Micro Investment LLC), Note Purchase Agreement (Micro Investment LLC)

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act Act, and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Market"), and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing delisting the Common Stock from the The Nasdaq National Stock Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") or the NASD is contemplating terminating such registration or listing.

Appears in 2 contracts

Samples: Preferred Stock and Warrant Purchase Agreement (Novatel Wireless Inc), Preferred Stock and Warrant Purchase Agreement (Cornerstone Equity Investors Iv Lp)

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Market"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") or the NASD is contemplating terminating such registration or listing.the

Appears in 1 contract

Samples: Securities Purchase Agreement (Aradigm Corp)

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National MarketNASDAQ NATIONAL MARKET"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") SEC or the NASD National Association of Securities Dealers, Inc. is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Securities Purchase Agreement (Aradigm Corp)

Nasdaq Compliance. The Company's ’s Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The the Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Market"“Nasdaq”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing the Common Stock from the Nasdaq National MarketNasdaq, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") SEC or the NASD Nasdaq is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Securities Purchase Agreement (Advanced Life Sciences Holdings, Inc.)

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and is listed quoted on The the Nasdaq Stock Market, Inc. National Market OTC Bulletin Board (the "Nasdaq National MarketBulletin Board"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing removing the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") or the NASD is contemplating terminating such registration or listingBulletin Board.

Appears in 1 contract

Samples: Stock Purchase Agreement (Nestor Inc)

Nasdaq Compliance. The Company's ’s Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Market"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") SEC or the NASD National Association of Securities Dealers, Inc. is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Securities Purchase Agreement (Aradigm Corp)

Nasdaq Compliance. The Company's ’s Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Market"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") SEC or the NASD is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Securities Purchase Agreement (Nanogen Inc)

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National MarketNASDAQ STOCK MARKET"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing delisting the Common Stock from the Nasdaq National Stock Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") or the NASD is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Stock Purchase Agreement (Lecroy Corp)

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Market"), . The Company is currently in full compliance with Nasdaq requirements and the Company has taken no will not take any action designed to, or likely which will cause it to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") or the NASD is contemplating terminating such registration or listingfail to comply.

Appears in 1 contract

Samples: Convertible Preferred Stock Purchase Agreement (Fastnet Corp)

AutoNDA by SimpleDocs

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Stock Market"), and neither the Company Company, nor to the knowledge of the Company, any third party has taken no any action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing delisting the Common Stock from the Nasdaq National Stock Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") or the NASD is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Note and Warrant Purchase Agreement (Ecollege Com)

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange 1934 Act and is listed on The the Nasdaq Stock Market, Inc. National Capital Market (the "Nasdaq National Market"“Nasdaq”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing the Common Stock from the Nasdaq National Market, nor has the Company not received any notification that the Securities and Exchange Commission (Commission, the "SEC") Nasdaq or the NASD Financial Industry Regulatory Authority, Inc. is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Purchase Agreement (Claudius IV, LLC)

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National SmallCap Market (the "Nasdaq National SmallCap Market"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing the Common Stock from the Nasdaq National SmallCap Market, nor has the Company received any notification that the SEC or the National Association of Securities and Exchange Commission Dealers, Inc. (the "SEC"“NASD”) or the NASD is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Securities Purchase Agreement (Solexa, Inc.)

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National MarketNASDAQ STOCK MARKET"), and the Company has taken no action designed to, or likely to have the effect of, terminating terminate the registration of the Common Stock under the Exchange Act or de-listing delisting the Common Stock from the Nasdaq National Stock Market. The Company is not aware of, nor and has the Company not received any notification that notice of, any efforts or actions to terminate the Securities and registration of the Common Stock under the Exchange Commission (Act or delist the "SEC") or Common Stock from the NASD is contemplating terminating such registration or listingNasdaq Stock Market.

Appears in 1 contract

Samples: Purchase Agreement (New Century Financial Corp)

Nasdaq Compliance. The Company's ’s Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Market")Nasdaq, and the Company has taken no action designed to, or which is reasonably likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing delisting the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") or the NASD is contemplating terminating such registration or listing.Nasdaq. The

Appears in 1 contract

Samples: Unit Purchase Agreement (Idm Pharma, Inc.)

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Market"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing the Common Stock from the Nasdaq National Market, nor has the Company any knowledge of any fact or circumstance that may give rise to such event or received any notification that the Securities and Exchange Commission (the "SEC") SEC or the NASD is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Securities Purchase Agreement (Orthovita Inc)

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Market"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") SEC or the NASD National Association of Securities Dealers, Inc. is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Securities Purchase Agreement (Metabasis Therapeutics Inc)

Nasdaq Compliance. The Company's Common Stock ’s common stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National Capital Market (the "Nasdaq National Capital Market"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock common stock under the Exchange Act or de-listing the Common Stock common stock from the Nasdaq National Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") or the NASD is contemplating terminating such registration or listing.the

Appears in 1 contract

Samples: Stock Purchase Agreement (Silicon Graphics Inc)

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Market"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the SEC or the National Association of Securities and Exchange Commission Dealers, Inc. (the "SECNASD") or the NASD is currently contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Stock and Warrant Purchase Agreement (Insmed Inc)

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Stock Market"), and the . The Company has taken no action designed tonot, or likely to have in the effect oftwelve (12) months preceding the Effective Date hereof, terminating the registration of the Common Stock under the Exchange Act or de-listing the Common Stock received written notice from the Nasdaq National Market, nor has Stock Market that the Company received any notification that is not in compliance with the Securities listing or maintenance requirements of the Nasdaq Stock Market. The issuance and Exchange Commission (sale of Shares hereunder does not contravene the "SEC") or rules and regulations of the NASD is contemplating terminating such registration or listingNasdaq Stock Market.

Appears in 1 contract

Samples: Purchase Agreement (Versicor Inc /Ca)

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Stock Market"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing the Common Stock from the Nasdaq National Stock Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") or the NASD is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Stock Purchase Agreement (Messagemedia Inc)

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act Act, and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Stock Market"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing delisting the Common Stock from the Nasdaq National Stock Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") or the NASD is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Securities Purchase Agreement (Napro Biotherapeutics Inc)

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Market"), and the . The Company has taken no action designed to, or which to its knowledge is reasonably likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing delisting of the Common Stock from the Nasdaq National Market, nor has the Company received any notification that . The issuance of the Securities and Exchange Commission (does not require shareholder approval pursuant to the "SEC") or the NASD is contemplating terminating such registration or listingNasdaq Marketplace Rules.

Appears in 1 contract

Samples: Common Stock Purchase Agreement (Fao Inc)

Nasdaq Compliance. The Company's ’s Common Stock is registered pursuant to Section 12(g12(b) of the Exchange Act and is listed on The the Nasdaq Stock Capital Market, Inc. National Market (the "Nasdaq National Market"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing the Common Stock from the Nasdaq National Capital Market, nor has the Company received any notification that the Securities and Exchange Commission SEC, the Financial Industry Regulatory Authority, Inc. (the "SEC") “FINRA”), or the NASD Nasdaq is contemplating terminating such registration or listing, except to the extent that the Company has resolved the issues raised in any such notification.

Appears in 1 contract

Samples: Stock and Warrant Purchase Agreement (Inhibitex, Inc.)

Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Stock Market"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing delisting the Common Stock from the Nasdaq National Stock Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") or the NASD is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Stock Purchase Agreement (Adolor Corp)

Time is Money Join Law Insider Premium to draft better contracts faster.